PortfoliosLab logo
ACA vs. TTEK
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ACA and TTEK is 0.58, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.6

Performance

ACA vs. TTEK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Arcosa, Inc. (ACA) and Tetra Tech, Inc. (TTEK). The values are adjusted to include any dividend payments, if applicable.

100.00%200.00%300.00%400.00%500.00%NovemberDecember2025FebruaryMarchApril
291.66%
167.65%
ACA
TTEK

Key characteristics

Sharpe Ratio

ACA:

0.10

TTEK:

-0.52

Sortino Ratio

ACA:

0.40

TTEK:

-0.54

Omega Ratio

ACA:

1.05

TTEK:

0.92

Calmar Ratio

ACA:

0.10

TTEK:

-0.37

Martin Ratio

ACA:

0.27

TTEK:

-0.77

Ulcer Index

ACA:

13.51%

TTEK:

21.40%

Daily Std Dev

ACA:

37.11%

TTEK:

31.80%

Max Drawdown

ACA:

-36.79%

TTEK:

-77.89%

Current Drawdown

ACA:

-28.00%

TTEK:

-38.02%

Fundamentals

Market Cap

ACA:

$3.91B

TTEK:

$8.44B

EPS

ACA:

$1.91

TTEK:

$0.95

PE Ratio

ACA:

42.01

TTEK:

32.85

PEG Ratio

ACA:

6.72

TTEK:

2.23

PS Ratio

ACA:

1.52

TTEK:

1.87

PB Ratio

ACA:

1.61

TTEK:

4.94

Total Revenue (TTM)

ACA:

$1.97B

TTEK:

$4.14B

Gross Profit (TTM)

ACA:

$403.60M

TTEK:

$689.93M

EBITDA (TTM)

ACA:

$234.50M

TTEK:

$340.66M

Returns By Period

In the year-to-date period, ACA achieves a -16.96% return, which is significantly higher than TTEK's -21.52% return.


ACA

YTD

-16.96%

1M

-1.94%

6M

-14.43%

1Y

3.99%

5Y*

15.74%

10Y*

N/A

TTEK

YTD

-21.52%

1M

5.80%

6M

-34.66%

1Y

-18.04%

5Y*

17.42%

10Y*

23.52%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ACA vs. TTEK — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ACA
The Risk-Adjusted Performance Rank of ACA is 5454
Overall Rank
The Sharpe Ratio Rank of ACA is 5656
Sharpe Ratio Rank
The Sortino Ratio Rank of ACA is 4949
Sortino Ratio Rank
The Omega Ratio Rank of ACA is 4949
Omega Ratio Rank
The Calmar Ratio Rank of ACA is 5858
Calmar Ratio Rank
The Martin Ratio Rank of ACA is 5656
Martin Ratio Rank

TTEK
The Risk-Adjusted Performance Rank of TTEK is 2626
Overall Rank
The Sharpe Ratio Rank of TTEK is 2323
Sharpe Ratio Rank
The Sortino Ratio Rank of TTEK is 2323
Sortino Ratio Rank
The Omega Ratio Rank of TTEK is 2222
Omega Ratio Rank
The Calmar Ratio Rank of TTEK is 2828
Calmar Ratio Rank
The Martin Ratio Rank of TTEK is 3535
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ACA vs. TTEK - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Arcosa, Inc. (ACA) and Tetra Tech, Inc. (TTEK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for ACA, currently valued at 0.10, compared to the broader market-2.00-1.000.001.002.003.00
ACA: 0.10
TTEK: -0.52
The chart of Sortino ratio for ACA, currently valued at 0.40, compared to the broader market-6.00-4.00-2.000.002.004.00
ACA: 0.40
TTEK: -0.54
The chart of Omega ratio for ACA, currently valued at 1.05, compared to the broader market0.501.001.502.00
ACA: 1.05
TTEK: 0.92
The chart of Calmar ratio for ACA, currently valued at 0.10, compared to the broader market0.001.002.003.004.005.00
ACA: 0.10
TTEK: -0.37
The chart of Martin ratio for ACA, currently valued at 0.27, compared to the broader market-5.000.005.0010.0015.0020.00
ACA: 0.27
TTEK: -0.77

The current ACA Sharpe Ratio is 0.10, which is higher than the TTEK Sharpe Ratio of -0.52. The chart below compares the historical Sharpe Ratios of ACA and TTEK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2025FebruaryMarchApril
0.10
-0.52
ACA
TTEK

Dividends

ACA vs. TTEK - Dividend Comparison

ACA's dividend yield for the trailing twelve months is around 0.25%, less than TTEK's 0.74% yield.


TTM20242023202220212020201920182017201620152014
ACA
Arcosa, Inc.
0.25%0.21%0.24%0.37%0.38%0.36%0.45%0.00%0.00%0.00%0.00%0.00%
TTEK
Tetra Tech, Inc.
0.74%0.57%0.61%0.61%0.45%0.57%0.66%0.89%0.81%0.81%1.19%0.79%

Drawdowns

ACA vs. TTEK - Drawdown Comparison

The maximum ACA drawdown since its inception was -36.79%, smaller than the maximum TTEK drawdown of -77.89%. Use the drawdown chart below to compare losses from any high point for ACA and TTEK. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2025FebruaryMarchApril
-28.00%
-38.02%
ACA
TTEK

Volatility

ACA vs. TTEK - Volatility Comparison

Arcosa, Inc. (ACA) has a higher volatility of 16.76% compared to Tetra Tech, Inc. (TTEK) at 11.03%. This indicates that ACA's price experiences larger fluctuations and is considered to be riskier than TTEK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%NovemberDecember2025FebruaryMarchApril
16.76%
11.03%
ACA
TTEK

Financials

ACA vs. TTEK - Financials Comparison

This section allows you to compare key financial metrics between Arcosa, Inc. and Tetra Tech, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items